{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-042968","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.465175+00:00","generated_at":"2026-05-30T19:09:55.677136+00:00","sec_items":["1.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Acasti Pharma redomiciles from Canada to Delaware effective October 7, 2024","bullets":["Changed jurisdiction from Quebec to British Columbia (Oct 1) and then to Delaware (Oct 7, 2024).","Shareholders approved continuance and domestication at Sept 30, 2024 meeting.","Rights of common stockholders now governed by Delaware General Corporation Law and new Charter/Bylaws.","Entered into indemnification agreements with each executive officer and director.","Common stock continues trading on Nasdaq under symbol ACST."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-042968","json":"https://secwatch.observer/filing/0001140361-24-042968.json","markdown":"https://secwatch.observer/filing/0001140361-24-042968.md","text":"https://secwatch.observer/filing/0001140361-24-042968.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000114036124042968/0001140361-24-042968-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000114036124042968/ef20036564_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:09:55.677136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26b1beb5ac9c0c0de779c0c500b9d94fad41a7e8","claim":"Grace Therapeutics, Inc.: Adoption of Certificate of Incorporation and Bylaws in Delaware following domestication (effective 2024-10-07).","evidence_excerpt":"The Charter and the Bylaws became effective as of October 7, 2024.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036124042968/0001140361-24-042968-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-10-07"}],"fact_type":"governance_change"},{"claim_id":"f92bd10af4a77f946d7f1fcf68120cabf0ae111f","claim":"Grace Therapeutics, Inc.: Adoption of Notice of Articles and Articles of Acasti British Columbia following continuance (effective 2024-10-01).","evidence_excerpt":"The Notice of Articles and the Articles became effective as of October 1, 2024.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036124042968/0001140361-24-042968-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Effective","value":"2024-10-01"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}